1. Comparison of medication adherence between fixed-dose combination of angiotensin receptor blockers and statin and free-combination therapy
- Author
-
Yu Jeong Jang, Mira Kang, Shin-Hye Lee, Jung Min Choi, and J.-H Choi
- Subjects
Statin ,Combination therapy ,business.industry ,medicine.drug_class ,Fixed-dose combination ,Medication adherence ,Medicine ,Angiotensin Receptor Blockers ,Pharmacology ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Non-adherence to angiotensin receptor blockers (ARB) or statin is one of major reasons of insufficient treatment for patients with hyperlipidemia and hypertension. We investigated whether fixed-dose combination (FDC) of ARB and statin improved adherence compared to traditional free combination (FC). Methods In this retrospective nationwide cohort study, adherence of 128,369 patients who started ARB and stain including atorvastatin or rosuvastatin between July 2014 and June 2015 was investigated. Primary endpoint was proportion of days covered (PDC) per 180 days up to day 540. Good compliance defined by PDC≥80% and persistency rate defined by patients remaining on medication were also investigated. Results Patients were 62.9 years of mean age with 48.2% female gender. Compared to FC (N=90,759, 70.7%), FDC (N=37,610, 29.3%) showed higher PDC at day 180 (86% vs 70%), 360 (77% vs 62%), and 540 (74% vs 55%, p Conclusions In this real-world data analysis, FDC resulted in higher medication adherence and persistence compared to FC among patients who started both ARB and atorvastatin or rosuvastatin. Persistence rate btw FDC and FC Funding Acknowledgement Type of funding source: None
- Published
- 2020
- Full Text
- View/download PDF